Findings demonstrate improved sperm preservation using a new cryopreservation protocol and cryoprotectant in a preclinical setting.
BACKGROUND: Sperm cryopreservation is essential for assisted reproductive technologies, yet current methods face challenges regarding cryoprotectant toxicity and protocol standardization. OBJECTIVE: To develop an optimized cryopreservation system by investigating cryoprotective mechanisms and establishing standardized freezing protocols without using any animal-derived material. MATERIALS AND METHODS: Thermodynamic analysis was performed to evaluate the cryoprotectant efficacy of glycerol (i.e., its ice crystal inhibition properties). An optimized formulation combining 10% glycerol with recombinant human serum albumin (rHSA) was developed to replace traditional egg yolk components. A novel freezing protocol incorporating gradient cooling and precise nucleation at −8.5°C was implemented using a custom-designed automated cryopreservation device (±1°C precision). RESULTS: The optimized formulation significantly reduced the melting enthalpy while it maintained post-thaw sperm motility of 75.4 ± 3.2% and DNA fragmentation index <15%. The freezing protocol achieved 82.6 ± 4.1% recovery rate and reduced ice crystal formation by 62.3%. Preclinical study demonstrated significant improvements versus conventional methods (increased motility by 27.8% and enhanced DNA integrity by 34.6%, both p < 0.01). CONCLUSION: The study established a standardized, pathogen-free cryopreservation system with demonstrated efficacy in preserving sperm quality. The findings provide both technical solutions for clinical practice and fundamental insights into cryoprotective mechanisms.
No takes yet. Share an insight, caveat, or question.
Li et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: